169 related articles for article (PubMed ID: 24947312)
1. Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm.
Archavlis E; Tselis N; Birn G; Ulrich P; Zamboglou N
J Neurooncol; 2014 Sep; 119(2):387-95. PubMed ID: 24947312
[TBL] [Abstract][Full Text] [Related]
2. Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy.
Archavlis E; Tselis N; Birn G; Ulrich P; Zamboglou N
Neurol Res; 2014 Dec; 36(12):1047-55. PubMed ID: 24852696
[TBL] [Abstract][Full Text] [Related]
3. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
4. Outcome of salvage treatment for recurrent glioblastoma.
Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
[TBL] [Abstract][Full Text] [Related]
5. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma: patterns of recurrence and efficacy of salvage treatments.
Oh J; Sahgal A; Sanghera P; Tsao MN; Davey P; Lam K; Symons S; Aviv R; Perry JR
Can J Neurol Sci; 2011 Jul; 38(4):621-5. PubMed ID: 21672702
[TBL] [Abstract][Full Text] [Related]
7. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
[TBL] [Abstract][Full Text] [Related]
9. Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.
Ogura K; Mizowaki T; Arakawa Y; Ogura M; Sakanaka K; Miyamoto S; Hiraoka M
Radiat Oncol; 2013 Apr; 8():97. PubMed ID: 24499582
[TBL] [Abstract][Full Text] [Related]
10. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
De Bonis P; Fiorentino A; Anile C; Balducci M; Pompucci A; Chiesa S; Sica G; Lama G; Maira G; Mangiola A
Clin Neurol Neurosurg; 2013 Jul; 115(7):883-6. PubMed ID: 22959214
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
12. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
Chamberlain MC; Tsao-Wei DD
Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
Arakawa Y; Mizowaki T; Murata D; Fujimoto K; Kikuchi T; Kunieda T; Takahashi JC; Takagi Y; Miyamoto S
Neurol Med Chir (Tokyo); 2013; 53(11):779-85. PubMed ID: 24140770
[TBL] [Abstract][Full Text] [Related]
15. Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.
Holt DE; Bernard ME; Quan K; Clump DA; Engh JA; Burton SA; Heron DE
J Cancer Res Ther; 2016; 12(4):1243-1248. PubMed ID: 28169234
[TBL] [Abstract][Full Text] [Related]
16. Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.
Scorsetti M; Navarria P; Pessina F; Ascolese AM; D'Agostino G; Tomatis S; De Rose F; Villa E; Maggi G; Simonelli M; Clerici E; Soffietti R; Santoro A; Cozzi L; Bello L
BMC Cancer; 2015 Jun; 15():486. PubMed ID: 26118437
[TBL] [Abstract][Full Text] [Related]
17. Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure.
Kukiełka AM; Hetnał M; Dąbrowski T; Walasek T; Brandys P; Nahajowski D; Kudzia R; Dybek D; Reinfuss M
Strahlenther Onkol; 2014 Feb; 190(2):165-70. PubMed ID: 24317192
[TBL] [Abstract][Full Text] [Related]
18. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
[TBL] [Abstract][Full Text] [Related]
19. Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients.
Socha J; Kepka L; Ghosh S; Roa W; Kumar N; Sinaika V; Matiello J; Lomidze D; de Castro DG; Hentati D; Fidarova E
J Neurooncol; 2016 Feb; 126(3):493-8. PubMed ID: 26542030
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.
Lee B; Shinohara K; Weinberg V; Gottschalk AR; Pouliot J; Roach M; Hsu IC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1106-12. PubMed ID: 17197119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
